 A few medicines are dosed even in normal renal function on that derived GFR.The dose, unless further modified, could now be higher than desired, potentially causing increased drug-related toxicity.To counter the effect of changing to IDMS, new FDA guidelines have suggested limiting doses to specified maxima with carboplatin, a chemotherapy drug.